Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil prevents serotonin loss from MDMA by affecting potassium channels and increasing Akt phosphorylation.

Finasteride increases CD8+ T cells in BPH tissues.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

The diphosphonate was the most effective at preventing calcification in rats.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Isotretinoin and acitretin may effectively stabilize the hairline in patients with frontal fibrosing alopecia.

FGF5s can block the effects of FGF5, which may help control hair growth in cashmere goats.

Potential compounds may inhibit hair loss by targeting a non-androgen pathway.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Spanlastic formulations improve rivaroxaban's oral anticoagulation efficiency.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Recombinant Filaggrin-2 microneedles effectively promote hair growth and repair in hair loss.

These medications for BPH have known risks and may have new side effects.

New treatments improved blood pressure control in patients with resistant hypertension.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Superhydrophobic surfaces can prevent fouling and enable self-cleaning in microfluidic devices.

Potential compounds may inhibit hair loss by targeting a non-androgen pathway.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

KATP channel openers may cause peripheral edema by reducing lymphatic contractions and flow.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Blocking cholesterol production may help control hair loss in Primary Cicatricial Alopecia by affecting key regulators.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.